81 episodes

Dr. Joe Chaffin from the "Blood Bank Guy" website takes his light-hearted approach to a biweekly interview show, discussing core transfusion medicine topics with educational leaders. You'll smile, and have fun, and never EVER stop learning!

Blood Bank Guy Essentials Podcast Joe Chaffin, MD

    • Medicine

Dr. Joe Chaffin from the "Blood Bank Guy" website takes his light-hearted approach to a biweekly interview show, discussing core transfusion medicine topics with educational leaders. You'll smile, and have fun, and never EVER stop learning!

    079: Pioneering Pathogen Reduction with Ray Goodrich

    079: Pioneering Pathogen Reduction with Ray Goodrich

    With the FDA's 2019 publication of their Final Guidance on how to prevent patients from receiving platelet products contaminated with bacteria, it finally feels like pathogen reduction technology is about to "get real" in the United States! There was a time, though, that modern versions of pathogen reduction existed only in the minds of some really, really smart people. One of those brilliant minds is my guest, and his name is Dr. Ray Goodrich. Ray shares the backstory of how modern pathogen reduction techniques came to be.

    • 54 min
    078CE: Does That Patient REALLY Need Platelets? with Joe Sweeney

    078CE: Does That Patient REALLY Need Platelets? with Joe Sweeney

    Continuing education episode! Far too many platelet transfusion decisions are made by evaluating a single laboratory value (the platelet count). Dr. Joe Sweeney believes we need more information to make better choices. Platelet transfusion decisions can be complex, and there is wide practice variability both within institutions and among different subspecialty services. In this interview, Dr. Sweeney describes current platelet transfusion guidelines and a more thorough approach to caring for thrombocytopenic patients.

    • 55 min
    077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

    077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

    Continuing education episode! On September 30, 2019, the United States Food and Drug Administration released the long awaited final guidance on bacterial risk control in platelets (see episode 076 for more details). One way that transfusion services can fulfill the recommendations in the guidance is to implement pathogen reduction technology. Dr. Pat Kopko and her team at the University of California-San Diego are well ahead of the curve, as they implemented PR-platelets in their hospital WAY back in 2017! Along the way, UCSD and their blood supplier (American Red Cross) had to answer many difficult questions and make many decisions (Why can't we just "flip a switch" and go from zero to 100% with PR-platelet supply? If we can't get to 100% right away, which patients get them first? And many more...). Pat joins me to describe lessons learned, with an eye toward where this all fits with the recent guidance.

    • 52 min
    076: FDA Platelet Bacteria Guidance with Pat Kopko

    076: FDA Platelet Bacteria Guidance with Pat Kopko

    Over the past several years, the United States Food and Drug Administration has considered many proposals for how to decrease the risk that a vulnerable patient would receive a platelet transfusion containing bacteria. On September 30, 2019, FDA released their "Final Guidance" with multiple recommendations that can appear confusing at first glance. This interview with Dr. Pat Kopko from UC-San Diego is designed to be a "first impression" tour through the options in the guidance. NOTE: Every facility should form their own impressions and determine their individual best course. I highly recommend focused conversations between blood suppliers and transfusion services to decide what is best in YOUR setting!

    • 42 min
    075CE: What About Fibrinogen? with Melissa Cushing

    075CE: What About Fibrinogen? with Melissa Cushing

    Continuing education episode! Are we ignoring the most important coag factor when transfusing bleeding patients? Melissa Cushing thinks the contribution of replacing critically low fibrinogen levels to survival of bleeding patients may be under-recognized. She describes the current evidence for early fibrinogen replacement in the bleeding patient, logistical challenges transfusion services face, studies providing insights to desired fibrinogen target levels, and future options to provide early fibrinogen replacement with increased efficiency and safety.

    • 57 min
    074CE: Radioactive! with Chris Tormey

    074CE: Radioactive! with Chris Tormey

    Continuing education episode! Transfusion-associated Graft-versus-Host Disease (TA-GVHD) is a notoriously deadly but thankfully rare transfusion complication. Blood banks have used irradiation of cellular blood products for decades to prevent TA-GVHD, but clinicians and laboratorians still sometimes misunderstand what irradiation does and does not do.
    Dr. Chris Tormey, co-author of a 2018 article in Archives of Pathology and Laboratory Medicine on this topic, is my guest on today's interview. Dr. Tormey details the past, present, and future of blood product irradiation in this practical and timely interview.

    • 58 min

Customer Reviews

Rounak_D ,

Love the podcasts !!

Learning about Blood Banking and Transfusion Medicine was never so much fun !! Very relevant, very interesting and quite motivating. Thanks a lot sir !!

zainul abideen neelambra ,

pathologist

good resources for resource scarce nations and professionals in blood banking.

always try to make it simpler,though,very difficult.

good luck and keep going!!

Top Podcasts In Medicine

Listeners Also Subscribed To